SCHEMBL6696510

SCHEMBL6696510

CCOC(=O)c1cccc(NCC2CCC(=O)NC2=O)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.48
RAB9A P51151 4/20 0.47
SMN1; SMN2 Q16637 4/20 0.47
NPC1 O15118 3/20 0.47
KDM4E B2RXH2 1/20 0.47
CRBN Q96SW2 1/20 0.46
KMT2A Q03164 4/20 0.46
TSHR P16473 1/20 0.46
NPSR1 Q6W5P4 1/20 0.45
TP53 P04637 1/20 0.45
POLB P06746 2/20 0.44
CYP1A2 P05177 1/20 0.44
CYP2C9 P11712 1/20 0.44
HPGD P15428 1/20 0.44
CYP2C19 P33261 1/20 0.44
PKM P14618 1/20 0.44
LMNA P02545 3/20 0.43
MEN1 O00255 2/20 0.43
ALOX5 P09917 1/20 0.43
CDC25B P30305 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6700609 0.85 CRBN (0.55) ALDH1A1SMN1; SMN2NPC1CRBNKMT2A
SCHEMBL4390838 0.82 GAA (0.47) CRBN
SCHEMBL31443938 0.78 CRBN (0.48) CRBN
SCHEMBL6695895 0.76 CRBN (0.51) ALDH1A1RAB9ASMN1; SMN2NPC1CRBN
SCHEMBL31443704 0.76 CRBN (0.49) CRBN
SCHEMBL4400484 0.75 KIF11 (0.48) SMN1; SMN2CRBNPKM
SCHEMBL4398954 0.75 CRBN (0.60) CRBN
SCHEMBL22033222 0.74 SMN1; SMN2 (0.45) ALDH1A1RAB9ASMN1; SMN2NPC1KDM4E
SCHEMBL3092388 0.73 KMT2A (0.63) ALDH1A1RAB9ASMN1; SMN2NPC1KDM4E
SCHEMBL31443822 0.72 CRBN (0.53) CRBN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1185215-C Substituted glutarimides and use thereof IL-12 production inhibitors GRUENENTHAL GMBH (DE) 2005-01-19 CN disclosed
US-20040048859-A1 Substituted glutarimides and their use as inhibitors of IL-12 production GRUENENTHAL GMBH (DE) 2004-03-11 US disclosed
US-20030064987-A1 Substituted glutarimides and their use as inhibitors of IL-12 production GRUENENTHAL GMBH 2003-04-03 US disclosed
CN-1394201-A Substituted glutarimides and use thereof IL-12 production inhibitors GRUENENTHAL GMBH (DE) 2003-01-29 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040048859-A1 Substituted glutarimides and their use as inhibitors of IL-12 production GCDH, IL4I1, IL2 ALDH1A1 142/4885RAB9A 3928/4885SMN1; SMN2 2343/4885
US-20030064987-A1 Substituted glutarimides and their use as inhibitors of IL-12 production GCDH, IL4I1, IL2 ALDH1A1 142/4885RAB9A 3928/4885SMN1; SMN2 2343/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.